Apareció en

SVEPM Conference, 2018

Autores

Sánchez-Matamoros, A.; Boix, O.; Ruiz, M. C.; Woodward, M.; Maldonado, J.

These two studies were aimed to evaluate the efficacy of ERAVAC® in naïve rabbits up to 6 months after immunization, although protection for a longer period of time (up to 12 month) as an aid to establish the most adequate prevention program for the disease was also explored.

This study demonstrates the following:

• RHDV-2 vaccine stimulates the humoral response at 7 dpv, inducing high and long lasting antibody titers up to 12 mpv.

• RHDV-2 vaccine confers protective immunity to virulent heterologous challenge.

• A RHDV-2 prevention program could be based on a vaccination interval of at least 12 months.